NOXAFIL
Active substance: posaconazole
POWDER, FOR SUSPENSION · POSACONAZOLE 300 mg/1
United StatesActive
Marketing holder: Merck Sharp & Dohme LLC
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
- POSACONAZOLE · 300 mg/1
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 7 |
|
| EU 4 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-5175-74a6-b1e3-1a376381e16b,01a120c3-9aa8-75f8-9ca3-fc5f93db164d,01a120c3-b148-738a-8327-e3e9e0f503d1,01a120c4-bab1-79cf-aee7-2019681b49b8,01a120c4-bae2-7197-be7f-68a7dc75943b;count=7 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2b62-7ee4-b80c-f3baf58bd3fc,01a1208c-c51b-7a8e-b6db-0a46daecd082,01a1208d-586d-7aea-aa63-cd23b5a6a4d6,01a1208e-0aeb-76f0-a044-d0d0774d601d,01a1208e-38e2-74f8-bae5-64f40e739115;count=37 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 0085-2224
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
- product · openFDA NDC · 0085-2224 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0085-2224 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0085-2224 · Verified 2026-10-09 · open in source